Regencell Bioscience Holdings Ltd
About Regencell Bioscience Holdings Ltd
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$3.6M
- Total assets
- $5.8M
- Market cap
- $9.9B
- Operating margin
- 8.6%
- Net margin
- 3.6%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $3.2B
- Operating expenses
- $2.9B
- Operating income
- $271.7M
- Income tax
- $101.6M
- Net income
- $112.3M
- EPS (basic)
- $0.72
- EPS (diluted)
- $0.72
Balance sheet
- Total assets
- $2.8B
- Current assets
- $463.3M
- Total liabilities
- $3.7B
- Current liabilities
- $561.4M
- Shareholders’ equity
- -$855.8M
Cash flow
- Operating cash flow
- $409.9M
- Investing cash flow
- -$410.6M
- Financing cash flow
- -$17.0M
- Net cash flow
- -$17.7M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $9.9B
- P/E ratio
- 28.4
- EPS (diluted)
- $0.72
- Dividend yield
- 4.3%
- Shares outstanding
- 483.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 16, 2021
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $3.6M.
- Revenue grew 4% from FY2013 to FY2017.
- Trading 74% below its 52-week high.
- Pays a dividend yielding about 4.3% annually.
- Valued at a price-to-earnings (P/E) ratio of 28.4.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Regencell Bioscience Holdings Ltd.
Write a review
News about Regencell Bioscience Holdings Ltd
News & sentiment via Polygon.io
